Author(s): Raspagliesi F, Hanozet F, Ditto A, Solima E, Zanaboni F, et al.
Objective: The objective of this study was the prognostic analysis of clinicopathologic variables related to primary tumor and to lymph node metastases.
Methods: We retrospectively analyzed 389 cases of squamous cell carcinoma of the vulva. The following variables were studied: patients' age, diameter and location of the tumor, clinical tumor characteristics, depth of invasion, grade, lymphovascular space involvement (LVSI) and lymph node status. In the subset of 110 node positive patients, we evaluated number of positive nodes, laterality, extension of node dissection, lymph node chains involved, presence of extracapsular spread and rate of lymph node replacement. All variables with P value < 0.2 by the univariate analysis were successively subjected to multivariate analysis (Cox proportional hazard model).
Results: Among all the tumor-related variables age, clinical tumor characteristics, LVSI and lymph node status were found to be statistically significant predictors of survival for the log-rank test. On the basis of multivariate analysis, the nodal status was the most significant independent prognostic factor (hazard rate [HR]: 2.06; confidence interval [CI] 95%: 1.57-12.07) followed by LVSI (HR: 3.47; CI95%: 1.85-7.85). The independent prognostic factors among the variables relative to positive nodes were the percentage of nodal replacement (HR: 6.99; CI95%: 3.51-16.14) and the extracapsular spread (HR: 4.88; CI95%: 2.96-10.14).
Conclusions: Lymph node status and nodal features, such as extracapsular spread and nodal replacement rate, were shown to be independent factors. These factors should be considered to identify high risk patients and in planning further adjuvant therapy.
Referred From: https://www.ncbi.nlm.nih.gov/pubmed/16466657
Author(s): Judson PL, Habermann EB, Baxter NN, Durham SB, Virnig BA
Author(s): Hampl M, Deckers-Figiel S, Hampl JA, Rein D, Bender HG
Author(s): Jones RW, Baranyai J, Stables S
Author(s): Taussig FJ
Author(s): Falconer AD, Hirschowitz L, Weeks J, Murdoch J; South West Gynaecology Tumour Panel
Author(s): Rhodes CA, Cummins C, Shafi MI
Author(s): Levenback C, Morris M, Burke TW, Gershenson DM, Wolf JK, et al.
Author(s): Micheletti L, Preti M, Zola P, Zanotto Valentino MC, Bocci C, et al.
Author(s): [No authors listed]
Author(s): Benedet JL, Bender H, Jones H 3rd, Ngan HY, Pecorelli S
Author(s): Rutledge F, Smith JP, Franklin EW
Author(s): Boutselis JG
Author(s): Japaze H, Garcia-Bunuel R, Woodruff JD
Author(s): Benedet JL, Turko M, Fairey RN, Boyes DA
Author(s): Cavanagh D, Shepherd JH
Author(s): Cavanagh D, Roberts WS, Bryson SC, Marsden DE, Ingram JM, et al.
Author(s): Hacker NF, Berek JS, Lagasse LD, Leuchter RS, Moore JG
Author(s): Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS
Author(s): Rodolakis A, Diakomanolis E, Voulgaris Z, Akrivos T, Vlachos G, et al.
Author(s): Beller U, Quinn MA, Benedet JL, Creasman WT, Ngan HY
Author(s): Chan JK, Sugiyama V, Pham H, Gu M, Rutgers J, et al.
Author(s): Dhar KK, Woolas RP
Author(s): Saito T, Kato K
Author(s): Marsden DE, Hacker NF
Author(s): Hoffman JS, Kumar NB, Morley GW
Author(s): Hacker NF, Berek JS, Lagasse LD, Nieberg RK, Leuchter RS
Author(s): Monaghan JM, Hammond IG
Author(s): Lingard D, Free K, Wright RG, Battistutta D et al.
Author(s): Atamdede F, Hoogerland D
Author(s): Van Der Velden J, Kooyman CD, Van Lindert AC, Heintz A
Author(s): Rhodes CA, Cummins C, Shafi MI
Author(s): Reuben DB, Mor V, Hiris J
Author(s): Barnes EA, Thomas G
Author(s): Barbera L, Thomas G, Elit L, Covens A, Fyles A, et al.